Display options
Cite
Olubamwo OO, Onyeka IN, Aregbesola A, et al. Determinants of hospitalizations for pneumonia among Finnish drug users. SAGE Open Med. 2018;6:2050312118784311doi: 10.1177/2050312118784311.
Olubamwo, O. O., Onyeka, I. N., Aregbesola, A., Ronkainen, K., Tiihonen, J., Föhr, J., & Kauhanen, J. (2018). Determinants of hospitalizations for pneumonia among Finnish drug users. SAGE open medicine, 62050312118784311. https://doi.org/10.1177/2050312118784311
Olubamwo, Olubunmi O, et al. "Determinants of hospitalizations for pneumonia among Finnish drug users." SAGE open medicine vol. 6 (2018): 2050312118784311. doi: https://doi.org/10.1177/2050312118784311
Olubamwo OO, Onyeka IN, Aregbesola A, Ronkainen K, Tiihonen J, Föhr J, Kauhanen J. Determinants of hospitalizations for pneumonia among Finnish drug users. SAGE Open Med. 2018 Jun 27;6:2050312118784311. doi: 10.1177/2050312118784311. eCollection 2018. PMID: 30013782; PMCID: PMC6041852.
Copy Download .nbib Format: NLM
Share it on

SAGE Open Med. 2018 Jun 27;6:2050312118784311. doi: 10.1177/2050312118784311. eCollection 2018.

Determinants of hospitalizations for pneumonia among Finnish drug users.

SAGE open medicine

Olubunmi O Olubamwo, Ifeoma N Onyeka, Alex Aregbesola, Kimmo Ronkainen, Jari Tiihonen, Jaana Föhr, Jussi Kauhanen

Affiliations

  1. Institute of Public Health and Clinical Nutrition, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.
  2. Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland.
  3. Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
  4. Helsinki Deaconess Institute, Helsinki, Finland.

PMID: 30013782 PMCID: PMC6041852 DOI: 10.1177/2050312118784311

Abstract

OBJECTIVE: The study examined the determinants of being hospitalized for pneumonia in a large cohort of drug users.

METHODS: Information of 4817 clients seeking treatment for illicit drug use was linked with the Finnish hospital discharge register to identify those who were hospitalized with main/primary diagnoses of pneumonia during 1997-2013. Cox regression models were used to examine the association between age, gender, homelessness, and route of drug administration of the primary drug at initial clinical consultation and pneumonia hospitalization. Findings were presented as adjusted hazard ratios and 95% confidence intervals.

RESULTS: There were 354 persons diagnosed with pneumonia, with a total of 522 hospitalizations at the end of 2013. The univariate Cox models revealed that being over 44 years of age, male gender, homelessness, and intravenous drug use at initial clinical consultation increased the risk of being hospitalized for pneumonia. In the fully adjusted multivariate model, being over 44 years was the strongest factor independently associated with pneumonia hospitalization (adjusted hazard ratio: 2.67, 95% confidence interval: 1.56-4.57,

CONCLUSION: Vaccination, measures addressing housing instability, safe injecting and good hygienic practices, and treating underlying drug use problems could help to reduce morbidity for pneumonia in this cohort.

Keywords: Substance abuse; epidemiology; hospitalization; morbidity; pneumonia; register linkage; risk factor

Conflict of interest statement

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

  1. Clin Infect Dis. 1996 Jul;23(1):107-13 - PubMed
  2. Biogerontology. 2016 Jun;17(3):449-65 - PubMed
  3. J Neuroimmune Pharmacol. 2011 Dec;6(4):442-65 - PubMed
  4. Curr Opin Psychiatry. 2009 May;22(3):287-92 - PubMed
  5. Chem Biol Interact. 2013 Dec 5;206(3):444-51 - PubMed
  6. Medicine (Baltimore). 2008 Nov;87(6):329-34 - PubMed
  7. J Addict Dis. 2012;31(4):350-62 - PubMed
  8. Chest. 1995 Aug;108(2):460-3 - PubMed
  9. Infection. 2008 Jun;36(3):231-6 - PubMed
  10. Curr Opin Pulm Med. 2001 Mar;7(2):43-61 - PubMed
  11. Medicine (Baltimore). 2007 Mar;86(2):103-11 - PubMed
  12. Respir Med. 2013 Aug;107(8):1266-70 - PubMed
  13. PLoS One. 2009 Sep 29;4(9):e7255 - PubMed
  14. N Engl J Med. 2015 Jul 30;373(5):415-27 - PubMed
  15. Respirology. 2011 Oct;16(7):1119-26 - PubMed
  16. Q J Med. 1987 Sep;64(245):783-90 - PubMed
  17. CMAJ. 2006 Jul 18;175(2):149-54 - PubMed
  18. Am J Public Health. 2013 Dec;103 Suppl 2:S289-93 - PubMed
  19. N Engl J Med. 2011 Dec 15;365(24):2287-95 - PubMed
  20. Thorax. 1990 Dec;45(12):957-61 - PubMed
  21. Eur Respir J. 1993 May;6(5):750-2 - PubMed
  22. Am J Infect Control. 2013 Oct;41(10):880-4 - PubMed
  23. Radiographics. 2002 Oct;22 Spec No:S119-35 - PubMed
  24. BMC Med Inform Decis Mak. 2013 Mar 15;13:36 - PubMed
  25. Clin Infect Dis. 2013 Aug;57(3):362-7 - PubMed
  26. Chin J Physiol. 2014 Oct 31;57(5):295-8 - PubMed
  27. J Thorac Imaging. 2007 May;22(2):199-206 - PubMed
  28. Br J Dermatol. 2004 Jan;150(1):1-10 - PubMed

Publication Types